HS 3002Chemicals & pharmaPromising
Vaccines, blood & immunological products
Official description: Humn, anml, bld fr mdcnl use; modified imunlgcl prdt whether or not_bitech prcs; vccn
India imported ₹14.0k cr of vaccines, blood & immunological products in FY26, growing about 10% a year over five years. Every rupee of that is a market an Indian maker could win. Below: the market, who supplies it today, and how to start, with investment, licences, documents, schemes and contacts.
Sign in to see this business in full
Free account. Opportunity score, import trend, top supplier countries, industry news, and the complete start-up guide: investment, licences, documents, schemes and contacts.
Takes 30 seconds · Sign in with Google or a verified email